Kurse werden geladen...
Prognose
Das durchschnittliche Kursziel der Analysten beträgt 1,89€(−82,66%). Der Median liegt bei 1,74€(−84,04%).
| Kaufen | 4 |
| Halten | 12 |
| Verkaufen | 2 |
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?
From a technical perspective, Amarin Corporation PLC (AMRN) is looking like an interesting pick, as it just reached a key level of support. AMRN's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.» Mehr auf zacks.com
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
Here is how Amarin (AMRN) and GSK (GSK) have performed compared to their sector so far this year.» Mehr auf zacks.com
Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?
Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.» Mehr auf zacks.com
Unternehmenszahlen
| (EUR) | März 2025 | |
|---|---|---|
| Umsatz | 38,84 Mio | 25,79% |
| Bruttoeinkommen | 23,23 Mio | 19,45% |
| Nettoeinkommen | −14,51 Mio | 57,33% |
| EBITDA | −14,81 Mio | 24,69% |
Fundamentaldaten
| Metrik | Wert |
|---|---|
Marktkapitalisierung | 4,51 Mrd€ |
Anzahl Aktien | 413,42 Mio |
52 Wochen-Hoch/Tief | 14,26€ - 6,09€ |
| Dividenden | Nein |
Beta | 0,72 |
KGV (PE Ratio) | −58,96 |
KGWV (PEG Ratio) | 5,90 |
KBV (PB Ratio) | 10,94 |
KUV (PS Ratio) | 24,32 |
Unternehmensprofil
| Name | Amarin Co. ADR |
| CEO | Aaron D. Berg |
| Mitarbeiter | 275 |
Assets entdecken
Shareholder von Amarin Co. ADR investieren auch in folgende Assets
